Lightning Round: Medline is 'unbelievable', it's a buy, says Jim Cramer

Watch on YouTube ↗  |  January 17, 2026 at 00:44  |  6:15  |  CNBC
Speakers
Jim Cramer — Host, Mad Money
Matthew — Caller
Mark — Caller

Summary

Jim Cramer hosts a Mad Money Lightning Round, taking stock questions from callers. He gives buy recommendations on Medline, STMicroelectronics, UiPath, Nvidia, Oscar Health, Huntington National Bank, and KeyCorp, while advising against or to sell Super Micro, Alkermes, Smith & Nephew, Constellation Energy, and Vistra. He cites CEO confidence, valuation and growth, commoditization, and political uncertainty as key drivers.

  • Cramer conducts a stock-picking Lightning Round.
  • Medline is called unbelievable and a buy.
  • Cramer prefers Nvidia over Super Micro in AI hardware.
  • He is positive on STMicro, UiPath, Oscar Health, Huntington, and Key.
  • He is negative on Alkermes, Smith & Nephew, Constellation Energy, and Vistra.
  • Constellation and Vistra are flagged for political uncertainty and big gains.
Ideas
Jim Cramer Host, Mad Money 0:52
Likes Oscar with Bertolini as CEO
Cramer would go with Oscar Health because CEO Mark Bertolini is running the company and he likes him a lot; if Bertolini were not running it, he would not be as positive.
OSCR LOW
Jim Cramer Host, Mad Money 1:16
Own Nvidia, avoid Super Micro
In the AI hardware/server area, Cramer says investors do not need Super Micro and should move on; the stock to own in that area is Nvidia, period.
SMCI HIGH
Jim Cramer Host, Mad Money 1:16
Own Nvidia, avoid Super Micro
In the AI hardware/server area, Cramer says investors do not need Super Micro and should move on; the stock to own in that area is Nvidia, period.
NVDA HIGH
Jim Cramer Host, Mad Money 1:32
Alkermes weak hold, avoid
Alkermes has failed to do better by this point; Cramer does not recommend the stock and considers it at best a weak hold.
ALKS MED
Jim Cramer Host, Mad Money 1:50
Favors Huntington and Key banks
Cramer says Huntington National Bank always comes through and is terrific, and he also likes Key, calling them two terrific banks.
HBAN KEY LOW
Jim Cramer Host, Mad Money 2:39
UiPath upside beckons despite wait
Cramer thinks UiPath is ready now and praises CEO Daniel Dines; investors may have to wait a bit longer, but the upside beckons.
PATH MED
Jim Cramer Host, Mad Money 2:59
Smith & Nephew commoditized, must sell
Smith & Nephew is in a commoditized group Cramer does not like; he says the stock has to be sold, using the example that knee implant choices do not matter to patients.
SNN MED
Jim Cramer Host, Mad Money 3:28
Medline is unbelievable buy
Cramer calls Medline unbelievable and says it is a buy, making it one of his recommended buys.
MDL HIGH
Jim Cramer Host, Mad Money 3:51
Buy STMicro, cheap with growth
STMicro is cheap and good; while it trades around 40 times earnings, that is actually okay given growth, and Cramer would be a buyer.
STMPA MED
Jim Cramer Host, Mad Money 4:33
Move on from Constellation, Vistra
When the president gets involved, it is too uncertain, and with big gains in the stock, it is time to move on from Constellation Energy and Vistra.
CEG VST MED
Up Next
1:09
Jim Cramer talk Micron breaking ground on New York chip plant
CNBC · Jan 17
11:34
What’s Driving European Stocks in 2026
Morgan Stanley · Jan 17
12:00
Jim Cramer looks ahead to next week's market game plan
CNBC · Jan 17
2:10
We are starting to see green shoots in the housing market, says Jim Cramer
CNBC · Jan 17
1:29:47
Russell 2000 Rallies as Small Caps Outperform Broader Market | The Close 1/16/2026
Bloomberg Markets · Jan 17

This CNBC video, published January 17, 2026, features Jim Cramer discussing OSCR, SMCI, NVDA, ALKS, HBAN, KEY, PATH, SNN, MDL, STMPA, CEG, VST. 10 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Jim Cramer  · Tickers: OSCR, SMCI, NVDA, ALKS, HBAN, KEY, PATH, SNN, MDL, STMPA, CEG, VST